Buy EAM-2201 powder online
Buy EAM-2201 powder online from an approved vendor. EAM-2201 for sale online(4′-ethyl-AM-2201, 5″-fluoro-JWH-210) is a designer drug which is belong the cannabinoid class. However, it was first identified in Japan in July 2012 as an ingredient in synthetic cannabis smoking blends. Furthermore, same with the closely related MAM-2201, EAM-2201 appears to be another compound invented by suppliers specifically for recreational use.
Eam2201
EAM-2201 (4-ethyl-AM-2201, 5-fluoro-JWH-210, SGT-14) is a drug that presumably acts as a potent agonist for the cannabinoid receptors.It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in Japan in July 2012 as an ingredient in synthetic cannabis smoking blends. Like the closely related MAM-2201 which had been first reported around a year earlier, EAM-2201 thus appears to be another novel compound invented by designer drug suppliers specifically for recreational use. Structurally, EAM-2201 is a hybrid of two known cannabinoid compounds JWH-210 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.
Features
This product is qualified as a Reference Material that has been manufactured and tested to meet ISO/IEC 17025 and ISO 17034 international standards
This research chemical is intended to be used as an analytical reference standard
Synonyms : JWH 210 N-(5-fluoropentyl) analog
Technical Information
Formal Name :(4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone
CAS Number : 1364933-60-7
Molecular Formula : C26H26FNO
Formula Weight : 387.5
Purity : ≥98%
Formulation : A neat solid
Chemical formula EAM-2201 : C₂₆H₂₆FNO
canonical SMILES
CCC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCCCCF
Identifiers
InChI
InChI=1S/C26H26FNO/c1-2-19-14-15-23(21-11-5-4-10-20(19)21)26(29)24-18-28(17-9-3-8-16-27)25-13-7-6-12-22(24)25/h4-7,10-15,18H,2-3,8-9,16-17H2,1H3
Available MS Data
| Used Instruments | Q Exactive Plus Orbitrap |
| No. of Spectral Trees | 2 |
| No. of Spectra | 236 |
| Tandem Spectra | MS1, MS2 |
| Ionization Methods | ESI |
| Analyzers | FT |
| Last Modification | 11/3/2016 9:38:29 AM |
Identificators
| InChI | InChI=1S/C26H26FNO/c1-2-19-14-15-23(21-11-5-4-10-20(19)21)26(29)24-18-28(17-9-3-8-16-27)25-13-7-6-12-22(24)25/h4-7,10-15,18H,2-3,8-9,16-17H2,1H3 |
| InChI Key | NSCXPXDWLZORPX-UHFFFAOYSA-N |
| Canonical SMILES | CCC1=CC=C(C2=CC=CC=C12)C(=O)C3=CN(C4=CC=CC=C43)CCCCCF |
| CAS | 1364933607 |
| Splash | |
| Other Names | (4-Ethylnaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone ; JWH 210 N-(5-fluoropentyl) analog ; Methanone, (4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]- |
EAM-2201 at a concentration of 50 µM negligibly inhibited CYP1A2-mediated phenacetin
O-deethylation, CYP2A6-mediated coumarin 7-hydroxylation, CYP2B6-mediated bupropion
hydroxylation, CYP2C8-catalyzed amodiaquine N-deethylation, CYP2C9-catalyzed diclofenac
4-hydroxylation, CYP2C19-mediated [S]-mephenytoin 4-hydroxylation, CYP2D6-mediated bufuralol
0
-hydroxylation and CYP3A4-mediated midazolam 10
-hydroxylation activities in human liver
microsomes
However, 30-min preincubation of human liver microsomes with EAM-2201 and reduced
β-nicotinamide adenine dinucleotide phosphate (NADPH) resulted in strong inhibition of
CYP2C8-catalyzed amodiaquine N-deethylation, CYP2C9-catalyzed diclofenac 40
-hydroxylation,
CYP2C19-mediated [S]-mephenytoin 40
-hydroxylation and CYP3A4-mediated midazolam
1
-hydroxylation activities, with IC50 values of 3.0, 6.7, 10.9 and 17.6 µM, respectively
EAM 2201 is for research purpose only. The quality is very good.
